Tromantadine
Systematic (IUPAC) name | |
---|---|
N-(1-adamantyl)-2-[2-(dimethylamino)ethoxy]acetamide | |
Clinical data | |
Trade names | Viru-Merz |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Topical (gel) |
Legal status | |
Legal status | |
Identifiers | |
CAS Number | 53783-83-8 |
ATC code | D06BB02 (WHO) J05AC03 |
PubChem | CID 64377 |
ChemSpider | 57947 |
UNII | H191JFG8WA |
KEGG | D07199 |
NIAID ChemDB | 007760 |
Chemical data | |
Formula | C16H28N2O2 |
Molar mass | 280.406 g/mol |
| |
| |
(what is this?) (verify) |
Tromantadine is an antiviral medicine used to treat herpes simplex virus. It is available in a topical gel under trade names Viru-Merz and Viru-Merz Serol. Its performance is similar to aciclovir.
Like rimantadine, amantadine, and adapromine, tromantadine is a derivative of adamantane.
Mechanism
Tromantadine inhibits the early and late events in the virus replication cycle.[1] It changes the glycoproteins of the host cells, therefore impeding the absorption of the virus. It inhibits penetration of the virus. It also prevents uncoating of the virions.
References
- ↑ Rosenthal KS, Sokol MS, Ingram RL, Subramanian R, Fort RC (December 1982). "Tromantadine: inhibitor of early and late events in herpes simplex virus replication". Antimicrob. Agents Chemother. 22 (6): 1031–6. doi:10.1128/aac.22.6.1031. PMC 185716. PMID 6297383.
External links
|
|
This article is issued from Wikipedia - version of the Sunday, April 03, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.